EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Musculoskeletal pain in Parkinson's disease: Association with dopaminergic deficiency in the caudate nucleus

Katarina Rukavina, Nicola Mulholland, Benjamin Corcoran, Magdalena Krbot Skoric, Juliet Staunton, Silvia Rota, Pavlos Zinzalias, Kit Wu, Anna Fieldwalker, Kirsty Bannister, Alexandra Rizos, K Ray Chaudhuri

European Journal of Pain · 2024-02 · 28 (2) · 244-251

DOI: 10.1002/ejp.2172 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pain, online erschienen am 16.08.2023. Verfasst von Katarina Rukavina und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Psychiatry, Psychology & Neuroscience at King's College London, London, UK. Hauptthemen laut MEDLINE: Parkinson Disease, Musculoskeletal Pain. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health Research, Mental Health Biomedical Research Centre, Dementia Unit at South London.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Musculoskeletal (MSK) pain affects over 80% of People with Parkinson's (PD, PwP) and may, in part, be dopaminergic in origin, as dopaminergic medication often leads to its relief.

Methods

PwP who underwent striatal dopamine transporter visualization with a radiopharmaceutical DaTscan™ ( 123 I‐Ioflupane Injection) using a single‐photon emission computed tomography (SPECT) as a part of their clinical‐diagnostic work up were enrolled in the “Non‐motor International Longitudinal Study” (NILS; UK National Institute for Health Research Clinical Research Network Number 10084) and included in this cross‐sectional analysis. The association between specific DaTscan binding ratios for each striatum, the caudate nucleus and putamen and clinical ratings for MSK pain (assessed using the King's Parkinson's Disease Pain Scale (KPPS)) were analysed.

Results

53 PwP (30.2% female; age: 63.79 ± 11.31 years; disease duration (DD): 3.32 (0.31–14.41) years; Hoehn & Yahr stage (H&Y): 2 (1–4); Levodopa Equivalent Daily Dose (LEDD): 543.08 ± 308.94 mg) were assessed and included in this analysis. MSK pain was highly prevalent (71.7% of all participants, mean KPPS Item 1 score 5.34 ± 4.76) and did not correlate with the motor symptoms burden (SCOPA‐Motor total score; p = 0.783) but showed a significant correlation with quality of life (PDQ‐8, r s = 0.290, p = 0.035). z‐scores for the caudate nucleus (Exp (B) = 0.367, 95% CI for Exp (B) 0.148–0.910, p = 0.031) and striatum (Exp (B) = 0.338, 95% CI for Exp (B) 0.123–0.931, p = 0.036), adjusted for DD, H&Y and LEDD, were significant determinants of MSK pain.

Conclusions

Our findings suggest an association between MSK pain in PwP and the severity of dopaminergic deficiency in the caudate nucleus. Significance In People with Parkinson's, musculoskeletal pain does not arise simply as a direct sequel to motor symptoms—instead, it is linked to the severity of dopaminergic depletion in the caudate nucleus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseMusculoskeletal PainHumansFemaleMiddle AgedAgedMaleCaudate NucleusLongitudinal StudiesCross-Sectional StudiesQuality of LifeDopamineLevodopaNortropanes

Substanzen

DopamineLevodopaioflupaneNortropanes

Autor:innen und Institutionen

  • Institute of Psychiatry, Psychology & Neuroscience at King's College London, London, UK.
  • Parkinson's Foundation Centre of Excellence, King's College Hospital NHS Foundation Trust, London, UK.
  • Department of Nuclear Medicine, King's College Hospital NHS Foundation Trust, London, UK.
  • Laboratory for Cognitive and Experimental Neurophysiology, Department of Neurology, University Hospital Center Zagreb, Zagreb, Croatia.

Förderung

  • National Institute for Health Research
  • Mental Health Biomedical Research Centre
  • Dementia Unit at South London
  • Maudsley NHS Foundation Trust
  • King's College London

Zitieren

APA

Rukavina, K., Mulholland, N., Corcoran, B., Skoric, M. K., Staunton, J., Rota, S., Zinzalias, P., Wu, K., Fieldwalker, A., Bannister, K., Rizos, A., & Chaudhuri, K. R. (2024). Musculoskeletal pain in Parkinson's disease: Association with dopaminergic deficiency in the caudate nucleus. European Journal of Pain, 28(2), 244-251. https://doi.org/10.1002/ejp.2172

Vancouver

Rukavina K, Mulholland N, Corcoran B, Skoric MK, Staunton J, Rota S, et al. Musculoskeletal pain in Parkinson's disease: Association with dopaminergic deficiency in the caudate nucleus. European Journal of Pain. 2024;28(2):244-251. doi:10.1002/ejp.2172

BibTeX
@article{Rukavina2024,
  author = {Rukavina, Katarina and Mulholland, Nicola and Corcoran, Benjamin and Skoric, Magdalena Krbot and Staunton, Juliet and Rota, Silvia and Zinzalias, Pavlos and Wu, Kit and Fieldwalker, Anna and Bannister, Kirsty and Rizos, Alexandra and Chaudhuri, K Ray},
  title = {Musculoskeletal pain in Parkinson's disease: Association with dopaminergic deficiency in the caudate nucleus},
  journal = {European Journal of Pain},
  year = {2024},
  volume = {28},
  number = {2},
  pages = {244--251},
  doi = {10.1002/ejp.2172}
}
Kostenlos starten →